Literature DB >> 7333256

Modeling of dose-response relationships.

B Altshuler.   

Abstract

The main dose-response models for chronic toxicity are considered. For dichotomous response, the log probit, multi-hit, and multistage models are presented. For time-to-occurrence response, the log-normal and three variations of multistage models are presented. Finally, the Cornfield hockey-stick model is considered, and, for low-dose extrapolation, it is suggested that response be taken to be proportional to dose and to a power of time determined by background response.

Entities:  

Mesh:

Year:  1981        PMID: 7333256      PMCID: PMC1568781          DOI: 10.1289/ehp.814223

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  4 in total

1.  Carcinogenic risk assessment.

Authors:  J Cornfield
Journal:  Science       Date:  1977-11-18       Impact factor: 47.728

Review 2.  Estimation of risks of irreversible, delayed toxicity.

Authors:  D G Hoel; D W Gaylor; R L Kirschstein; U Saffiotti; M A Schneiderman
Journal:  J Toxicol Environ Health       Date:  1975-09

3.  Fundamental carcinogenic processes and their implications for low dose risk assessment.

Authors:  K S Crump; D G Hoel; C H Langley; R Peto
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

4.  Estimation of "safe doses" in carcinogenic experiments.

Authors:  H O Hartley; R L Sielken
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

  4 in total
  20 in total

1.  Toward improved public health outcomes from urban nature.

Authors:  Danielle F Shanahan; Brenda B Lin; Robert Bush; Kevin J Gaston; Julie H Dean; Elizabeth Barber; Richard A Fuller
Journal:  Am J Public Health       Date:  2015-01-20       Impact factor: 9.308

Review 2.  The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.

Authors:  Jeffry Weers; Andy Clark
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

3.  Effects of acaricide treatment and host intrinsic factors on tick acquisition and mortality in Boran cattle.

Authors:  Emily Grzeda; Taylor Maurer; Clara Dannemann; Lemaly Ole Kibiriti; John Kioko; Christian Kiffner
Journal:  Parasitol Res       Date:  2017-10-05       Impact factor: 2.289

4.  Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.

Authors:  Stephen E Kurtz; Christopher A Eide; Andy Kaempf; Vishesh Khanna; Samantha L Savage; Angela Rofelty; Isabel English; Hibery Ho; Ravi Pandya; William J Bolosky; Hoifung Poon; Michael W Deininger; Robert Collins; Ronan T Swords; Justin Watts; Daniel A Pollyea; Bruno C Medeiros; Elie Traer; Cristina E Tognon; Motomi Mori; Brian J Druker; Jeffrey W Tyner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

5.  Spore Germination as a Target for Antifungal Therapeutics.

Authors:  Sébastien C Ortiz; Mingwei Huang; Christina M Hull
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

6.  Single toxin dose-response models revisited.

Authors:  Eugene Demidenko; S P Glaholt; E Kyker-Snowman; J R Shaw; C Y Chen
Journal:  Toxicol Appl Pharmacol       Date:  2016-11-12       Impact factor: 4.219

7.  Role of nanoparticle surface functionality in the disruption of model cell membranes.

Authors:  Babak Y Moghadam; Wen-Che Hou; Charlie Corredor; Paul Westerhoff; Jonathan D Posner
Journal:  Langmuir       Date:  2012-09-06       Impact factor: 3.882

8.  Is oxidative stress in mice brain regions diminished by 2-[(2,6-dichlorobenzylidene)amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carbonitrile?

Authors:  A C Fortes; A A C Almeida; G A L Oliveira; P S Santos; W De Lucca Junior; F J B Mendonça Junior; R M Freitas; J L Soares-Sobrinho; M F R Soares
Journal:  Oxid Med Cell Longev       Date:  2013-03-14       Impact factor: 6.543

9.  Relationship between acute and chronic disease epidemiology.

Authors:  L H Kuller
Journal:  Yale J Biol Med       Date:  1987 Jul-Aug

10.  Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.

Authors:  Christopher A Eide; Stephen E Kurtz; Andy Kaempf; Nicola Long; Anupriya Agarwal; Cristina E Tognon; Motomi Mori; Brian J Druker; Bill H Chang; Alexey V Danilov; Jeffrey W Tyner
Journal:  Leukemia       Date:  2020-02-24       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.